Mucosal surfaces covered by a layer of epithelial cells represent the largest and most critical interface between the organism and its environment. The barrier function of mucosal surfaces is performed by the epithelial layer and immune cells present in the mucosal compartment. As recently found, epithelial cells, apart from their participation in absorptive, digestive and secretory processes perform more than a passive barrier function and are directly involved in immune processes. Besides the well known role of epithelial cells in the transfer of polymeric immunoglobulins produced by lamina propria B lymphocytes to the luminal content of mucosals (secretory Igs), these cells were found to perform various other immunological functions, to interact with other cells of the immune system and to induce an efficient inflammatory response to microbial invasion: enzymic processing of dietary antigens, expression of class I and II MHC antigens, presentation of antigens to lymphocytes, expression of adhesive molecules mediating interaction with intraepithelial lymphocytes and components of extracellular matrix, production of cytokines and probable participation in extrathymic T cell development of intraepithelial lymphocytes. All these functions were suggested to influence substantially the mucosal immune system and its response. Under immunopathological conditions, e.g. during infections and inflammatory bowel and celiac diseases, both epithelial cells and intraepithelial lymphocytes participate substantially in inflammatory reactions. Moreover, enterocytes could become a target of mucosal immune factors. Mucosal immunosurveillance function is of crucial importance in various pathological conditions but especially in the case of the most frequent malignity occurring in the intestinal compartment, i.e. colorectal carcinoma. Proper understanding of the differentiation processes and functions of epithelial cells in interaction with other components of the mucosal immune system is therefore highly desirable.

Department of Immunology and Gnotobiology Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Biochem Biophys Res Commun. 1995 Apr 17;209(2):597-605 PubMed

Scand J Gastroenterol Suppl. 1988;151:62-9 PubMed

Folia Biol (Praha). 1970 Jun;16(3):177-87 PubMed

Trends Microbiol. 1994 Jan;2(1):10-4 PubMed

Dig Dis Sci. 1993 Aug;38(8):1377-87 PubMed

Int J Immunopharmacol. 1994 May-Jun;16(5-6):487-93 PubMed

Int Rev Immunol. 1994;11(1):15-30 PubMed

Gut. 1993 Mar;34(3):289-92 PubMed

Eur J Immunol. 1989 Aug;19(8):1513-6 PubMed

Curr Opin Immunol. 1993 Apr;5(2):247-52 PubMed

Histochemistry. 1989;91(3):235-44 PubMed

Immunology. 1989 Dec;68(4):497-502 PubMed

J Clin Invest. 1995 Jan;95(1):55-65 PubMed

Gastroenterology. 1994 Feb;106(2):533-9 PubMed

Curr Opin Immunol. 1994 Aug;6(4):518-25 PubMed

Digestion. 1990;46 Suppl 2:12-21 PubMed

Cell. 1993 Oct 22;75(2):253-61 PubMed

APMIS. 1995 Jan;103(1):1-19 PubMed

Cell. 1993 Oct 22;75(2):203-5 PubMed

Infect Immun. 1992 May;60(5):1729-33 PubMed

J Exp Med. 1994 Oct 1;180(4):1307-19 PubMed

Folia Biol (Praha). 1980;26(2):81-93 PubMed

Pediatr Res. 1991 Apr;29(4 Pt 1):396-9 PubMed

Infect Immun. 1993 Nov;61(11):4569-74 PubMed

J Exp Med. 1994 Jul 1;180(1):15-23 PubMed

J Exp Med. 1994 Jul 1;180(1):1-4 PubMed

Clin Immunol Immunopathol. 1995 Feb;74(2):170-6 PubMed

Ann N Y Acad Sci. 1983 Jun 30;409:96-113 PubMed

Int J Immunopharmacol. 1994 May-Jun;16(5-6):481-5 PubMed

Ann Allergy. 1994 Feb;72(2):135-41 PubMed

Scand J Immunol. 1981;13(5):467-72 PubMed

Eur J Immunol. 1992 Jan;22(1):273-7 PubMed

Adv Immunol. 1987;40:153-245 PubMed

Immunol Today. 1995 Jan;16(1):16-21 PubMed

Immunol Today. 1992 Dec;13(12):471-3 PubMed

J Exp Med. 1993 Sep 1;178(3):1115-9 PubMed

J Immunol. 1995 Mar 1;154(5):2051-62 PubMed

FASEB J. 1994 Oct;8(13):1041-7 PubMed

Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2700-4 PubMed

Bifidobacterium bifidum monoassociation of gnotobiotic mice: effect on enterocyte brush-border enzymes

Autoimmunity, immunodeficiency and mucosal infections: chronic intestinal inflammation as a sensitive indicator of immunoregulatory defects in response to normal luminal microflora

Brush border enzyme activities in the small intestine after long-term gliadin feeding in animal models of human coeliac disease

Natural killer cell activity in coeliac disease: effect of in vitro treatment on effector lymphocytes and/or target lymphoblastoid, myeloid and epithelial cell lines with gliadin